Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED AGM Information 2024

Sep 20, 2024

61842_rns_2024-09-20_9eb16593-d8d6-4439-ae82-7e64af6f2aa1.pdf

AGM Information

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in

September 20, 2024 The BSE Limited The National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited Exchange Plaza, Bandra-Kurla Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Scrip Code: SOLARA, SOLARAPP

Dear Sir / Madam,

Sub: Proceedings of the Seventh Annual General Meeting of the Company and disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

We wish to inform you that the Seventh Annual General Meeting (“AGM”) of the Company was held on Friday, September 20, 2024, through Video Conferencing and other Audio – Visual Means, and the business mentioned in the Notice dated July 22, 2024 were transacted.

In this regard, please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is for your information and records.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2024.09.20 11:47:14 +05'30'

S. Murali Krishna

Company Secretary

Encl.: as above

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in

SUMMARY OF PROCEEDINGS OF THE SEVENTH ANNUAL GENERAL MEETING OF THE COMPANY HELD THROUGH VIDEO CONFERENCING ON FRIDAY, SEPTEMBER 20, 2024, FROM 10:00 A.M TO 11:10 A.M.

Present:

Mr. R. Ramakrishnan Independent Director & Chairman of Board & Audit Committee
Dr. Kausalya Santhanam Independent Director & SRC & CSR committee Chairperson
Mr. Rajendra Kumar Srivastava Independent Director & NRC Chairman
Mr. Rajiv Vijay Nabar Independent Director
Mr. Arun Kumar Pillai Non-Executive Director
Mr. Manish Gupta Non-Executive Director
Mr. Poorvank Purohit Managing Director & CEO
Mr. M. Mohan Executive Director
Mr. Arun Kumar Baskaran Chief Financial Officer
Mr. S. Murali Krishna Company Secretary
Mr. Sathya Koushik Partner, M/s. Deloitte Haskins & Sells LLP, Chartered Accountants
Statutory Auditors of the Company
Mr. Preetham Hebbar Practising Company Secretary - Scrutinizer for the Voting process
Mr. A Mohan Kumar Secretarial Auditor

Mr. R. Ramakrishnan, Chairman, welcomed the Members to the Seventh Annual General Meeting (AGM) of the Company and introduced the Directors and other invitees present in the meeting to the Members. Company Secretary confirmed that the requisite quorum was present and requested Chairman to conduct the meeting. Chairman called the meeting to order.

The members were informed that the requisite Statutory Registers and other documents referred to in the Notice of the AGM were available for online inspection on request by the Members. Members who were present at the AGM and had not cast their votes electronically through remote e-voting were provided an opportunity to cast their votes through e-voting during the meeting.

Mr. Poorvank Purohit, Managing Director & CEO, delivered his speech.

Thereafter, Mr. R. Ramakrishnan, Chairman, invited queries from the Members of the Company, which was responded by Mr. Poorvank Purohit.

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in

With the consent of the Members present, the Notice convening the AGM, the Report of the Board of Directors and the accounts for the Financial Year ended March 31, 2024 and other matters as stated in the Notice, were taken as read.

Mr. S. Murali Krishna further informed that as per the provisions of the Companies Act, 2013 and SEBI Listing Regulations, the Company had provided remote e-voting facility to all the Members through CDSL E-Voting platform to vote on all the resolutions proposed to be passed at the Meeting.

The cut-off date for determining the members who are entitled to vote through e-voting facility as well as voting at the meeting was Friday, September 13, 2024. The e-voting period commenced on September 17, 2024, at 9.00 a.m. and ended on September 19, 2024, at 5.00 p.m.

The Chairman informed that the Board of Directors of the Company had appointed Mr. Preetham Hebbar, Practicing Company Secretary, as Scrutinizer for the meeting.

The following items of business as per the Notice of AGM dated July 22, 2024, were transacted at the meeting:

Item
No.
Description / Resolutions Type of
Resolution
Ordinary Business
1 Adoption of Audited Financial Statements (Standalone and
Consolidated)for the Financial Year ended March 31,2024
Ordinary
Resolution
2 Re-Appointment of Mr. Arun Kumar Pillai, retiring director, as a
Non-Executive Director
Ordinary
Resolution
3 Re-Appointment of Mr. Kartheek Chintalapati Raju, retiring
director,as a Non-Executive Director
Ordinary
Resolution
Special Business
4 Ratification of remuneration payable to the Cost Auditor for the
financialyear 2023-24
Ordinary
Resolution
5 Approval for Material Related Party Transactions/ Contracts/
Arrangements with Strides Pharma Science Limited up to₹400
Crores
Ordinary
Resolution
6 Appointment of Mr. Manish Gupta (DIN: 06805265) as a
Non‑Executive(Non‑Independent)Director of the Company
Ordinary
Resolution
7 Introduction and Implementation of Solara Employee Stock
Option Plan 2024 to the employees of the Company
Special
Resolution
8 Extension of Solara Employee Stock Option Plan 2024 to the
employees of SubsidiaryCompanies the Company
Special
Resolution

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in

Mr. S. Murali Krishna stated that the consolidated results of the voting would be declared along with the Scrutinizer’s Report to the Stock Exchanges where the shares of the Company are listed and posted on the Company’s website within two working days.

Mr. R. Ramakrishnan, Chairman, thanked the Members and concluded the meeting.

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2024.09.20 11:50:46 +05'30'

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942